Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice
- PMID: 17916337
- DOI: 10.1016/j.brainres.2007.08.063
Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice
Abstract
The amount of the glucose transporter type-1 (GLUT-1) is decreased in the hippocampus and cerebral cortex of AD patients. In this study we therefore wanted to investigate the causal relationship between beta-amyloid (Abeta), GLUT-1 and hippocampal atrophy in the brains of young (8 months) and old (18 months) APP/PS1 mice.
Methods: Abeta and GLUT-1 were visualized immunohistochemically. Abeta load, GLUT-1 amount, capillary density and GLUT-1 amount per capillary density were determined in cortical and hippocampal areas using computer-assisted analysis systems. Hippocampal atrophy was determined by calculating the width of the outer molecular layer of the dentate gyrus (DG).
Results: In 18-month-old APP/PS1 mice we found a reduced GLUT-1 amount in the hippocampus but no differences in capillary density. The DG of these mice contained the highest level of Abeta in combination with hippocampal atrophy, and a reduced GLUT-1 amount per capillary density. At 8 months, no differences were observed. The highest Abeta deposition was found in the DG, although fourfold less compared to 18-month-old mice.
Conclusions: We conclude that the GLUT-1 amount and capillary density in both wild type and transgenic mice decrease due to ageing. Further, a decreased amount of GLUT-1 is caused by decreased GLUT-1 amount/capillary density and not due to a reduced capillary density. We suggest that Abeta load in the hippocampus precedes the reduction of GLUT-1. A certain level of Abeta must be reached in the hippocampus, before it affects GLUT-1 amount/capillary density leading to further impairment of energy metabolism and hippocampal atrophy.
Similar articles
-
Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.Neurobiol Dis. 2005 Feb;18(1):134-42. doi: 10.1016/j.nbd.2004.09.009. Neurobiol Dis. 2005. PMID: 15649704
-
Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.J Comp Neurol. 1999 Aug 30;411(3):390-8. J Comp Neurol. 1999. PMID: 10413774
-
Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4837-42. doi: 10.1073/pnas.0330745100. Proc Natl Acad Sci U S A. 2003. PMID: 12697936 Free PMC article.
-
[The lesions of Alzheimer's disease: which therapeutic perspectives?].Bull Acad Natl Med. 2008 Feb;192(2):303-18; discussion 318-21. Bull Acad Natl Med. 2008. PMID: 18819685 Review. French.
-
A perspective on sporadic inclusion-body myositis: the role of aging and inflammatory processes.Neurology. 2006 Jan 24;66(2 Suppl 1):S1-6. doi: 10.1212/01.wnl.0000192259.34541.e4. Neurology. 2006. PMID: 16432135 Review.
Cited by
-
Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?Metab Brain Dis. 2015 Feb;30(1):345-52. doi: 10.1007/s11011-014-9563-y. Epub 2014 May 9. Metab Brain Dis. 2015. PMID: 24810634 Review.
-
Microglia and the Blood-Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions.Int J Mol Sci. 2023 May 23;24(11):9144. doi: 10.3390/ijms24119144. Int J Mol Sci. 2023. PMID: 37298096 Free PMC article. Review.
-
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.Int J Mol Sci. 2017 Sep 13;18(9):1965. doi: 10.3390/ijms18091965. Int J Mol Sci. 2017. PMID: 28902142 Free PMC article. Review.
-
Vascular contributions to Alzheimer's disease.Transl Res. 2023 Apr;254:41-53. doi: 10.1016/j.trsl.2022.12.003. Epub 2022 Dec 15. Transl Res. 2023. PMID: 36529160 Free PMC article. Review.
-
Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies.Mol Neurobiol. 2020 Apr;57(4):1966-1977. doi: 10.1007/s12035-019-01858-5. Epub 2020 Jan 3. Mol Neurobiol. 2020. PMID: 31900863 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous